ED
OCLR

Exane Derivatives’s Oclaro Inc. OCLR Stock Holding History

Exane Derivatives’s Portfolio OCLR Stock Details OCLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-520,788
Closed -$4.49M – 649
2017
Q3 		$4.49M Sell
520,788
-748
-0.1% -$6.74K 0.84% 22
2017
Q2 		$4.87M Buy
+521,536
New +$4.72M 1.05% 20

Other funds holding OCLR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Exane Derivatives's OCLR Position: Q4 2017 in Review

Exane Derivatives sold out of Oclaro Inc. (OCLR) in Q4 2017, closing a stake of 520,788 shares — an estimated $4.49M sold.

Exane Derivatives first reported a position in OCLR in Q2 2017 and held it in 2 quarters. The position peaked at $4.87M in Q2 2017. 249 funds tracked by Wall St. Rank hold OCLR as of Q4 2017.

  • Exane Derivatives reported no remaining Oclaro Inc. position as of Q4 2017 after selling out during the quarter.
  • Exane Derivatives sold 520,788 Oclaro Inc. shares in Q4 2017, an estimated $4.49M.
  • Exane Derivatives first reported a position in Oclaro Inc. in Q2 2017 and held it in 2 quarters.
  • Exane Derivatives's Oclaro Inc. position peaked at $4.87M in Q2 2017.
  • 249 funds tracked by Wall St. Rank held Oclaro Inc. as of Q4 2017.

Based on Exane Derivatives's 13F filing for Q4 2017, filed 29 Jan 2018.